RE: All threads from today have disappeared5 Apr 2021 23:14
New Investors - There you go, it did not take very long (just a few minutes) before 'maestro Is For No.1' obsessively retaliated with another Post (QED), and even obviously lied in this retaliation.
He/she states that I have Posted crazy figures should GDR Sell just 50k PCR Tests - I do not believe that GDR will only sell 50k PCR Tests, and actually to show how Stupid his suggestion is, we know that Beckman Coulter have already (just a few weeks into our Distribution Agreement) bought $400,000 worth of our PCR Tests - $400,000 converts to £287,660, which at £10 per Test = 28,766 sold to Beckman Coulter already !!!
So for 'maestro Is FOR No.1' to Post that I have Posted figures for just 50,000 Tests, is simply ridiculous, he somehow forgot to mention that my calculations are based on my belief GDR/BC will build up to selling 50,000 Tests/Day. Our Test supplier Cytiva can manufacture in excess of 10,000 Tests/Hour !!!
When I invest in a Company one of the Tools I use is to Calculate the business Potential, and I have Posted my calculations on this BB:-
I believe that GDR Mcap is potentially worth £300 mil Mcap, based on projected Sales and Profit.
I expect GDR to sell 50,000 RT-PCR Test units/day at £10 per Test = £500,000 per day revenue, at 60% profit margin = £300,000 per day profit.
Working on a 5 day week = 5 x £300,000 = £1,500,000 profit per week.
£1,500,000 x 50 wks per year = £75,000,000 profit per year.
Using a standard multiple of 4 for valuation = 4 x £75,000,000 = Mcap of £300,000,000
Mcap of £300,000,000 divided by about 64,000,000 shares = a potential SP of £4.68p
This Mcap valuation does not take into consideration a valuation of our POC; HCV. DOD or AIHL etc
The Distribution Agreement we have recently signed with Beckman Coulter is Massive and as David Budd stated in the Investors Presentation, 'The Importance of Beckman Coulter should NOT be Underestimated'.
David Budd stated in his Investors Presentation, last Friday, that the BC Sales Team are Aggressively Focused on Selling Our PCR Tests, in particular to End Users that do Not need EUA Approval !!!
Beckman Coulter are a Massive, Well Respected Company, based in the USA, and for them to Partner Our GDR is an 'AMAZING COLLABORATION'
Beckman Coulter have worked with Our GDR Tests since August 4th 2020, and once they completed this Development phase BC signed a Distribution Agreement with Our GDR !!!
BC (owned by $160 Billion Danaher) have invested a Lot of Money and Hard work into Our GDR Test and Analysis Development, since August 2020, and they work on 'Millions of Sells', not just a total of 50K Tests.
'maestro Is FOR No.1' also somehow forgot to mention that South Africa work on a 6 Monthly Buying cycle.
We achieved Approval to sell Our PCR Tests in South Africa on 30th September 2020 (6 months ago), therefore time is tight to be considered in this Purchasing Cycle IMO?
Goodnight, I am Fishing 2moro, and will be watching Our SP from the Ba